Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Qingdao Gaoce Technology
688556
5
Aerospace Nanhu Electronic Information Technology
688552
US OptionsDetailed Quotes
AKYA250516C2500
- 0.00
- 0.000.00%
15min DelayTrading May 8 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest2.50Strike Price0.00Turnover0.00%IV116.45%PremiumMay 16, 2025Expiry Date0.00Intrinsic Value100Multiplier8DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma11.55Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Akoya Biosciences Newsroom
CCORF Maintains Akoya Biosciences(AKYA.US) With Hold Rating, Cuts Target Price to $1.8
Akoya Biosciences Is Maintained at Hold by Canaccord Genuity
Akoya Biosciences Price Target Cut to $1.80/Share From $3.50 by Canaccord Genuity
Akoya Biosciences Analyst Ratings
Piper Sandler Maintains Akoya Biosciences(AKYA.US) With Hold Rating, Cuts Target Price to $1.65
Akoya Biosciences Analyst Ratings
Stephens Downgrades Akoya Biosciences(AKYA.US) to Hold Rating, Cuts Target Price to $1.8
Akoya Biosciences Cut to Equal-Weight From Overweight by Stephens & Co.
Akoya Biosciences Price Target Cut to $1.80/Share From $3.50 by Stephens & Co.
CCORF Maintains Akoya Biosciences(AKYA.US) With Hold Rating, Maintains Target Price $3.5
CCORF Maintains Akoya Biosciences(AKYA.US) With Hold Rating, Maintains Target Price $3.5
Craig-Hallum Maintains Akoya Biosciences(AKYA.US) With Hold Rating
Akoya Biosciences (AKYA) Receives a Hold From Craig-Hallum
Akoya Biosciences Analyst Ratings
Buy Rating Affirmed for Quanterix Amid Strong Q4 Performance and Strategic Merger With Akoya Biosciences
Akoya Biosciences: Hold Rating Amid Revenue Decline and Merger Uncertainties
Piper Sandler Maintains Akoya Biosciences(AKYA.US) With Hold Rating, Maintains Target Price $2.4
Piper Sandler Downgrades Akoya Biosciences(AKYA.US) to Hold Rating, Cuts Target Price to $2.4
BTIG Maintains Akoya Biosciences(AKYA.US) With Hold Rating
Analysts Offer Insights on Healthcare Companies: Akoya Biosciences (AKYA) and HCA Healthcare (HCA)
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
